scholarly journals WHY CARDIOVASCULAR MORTALITY IN MOSCOW IS LOWER THAN IN OTHER REGIONS OF THE RUSSIAN FEDERATION?

2015 ◽  
Vol 14 (2) ◽  
pp. 4-12
Author(s):  
N. V. Pogosova ◽  
R. G. Oganov ◽  
S. V. Suvorov
Keyword(s):  
Coronary Heart Disease ◽  
Heart Disease ◽  
Medical Care ◽  
Russian Federation ◽  
Cardiovascular Mortality ◽  
High Technology ◽  
Economic Level ◽  
The Russian Federation ◽  
In The Beginning ◽  
Cvd Mortality

Since 2003 there is a decline of cardiovascular (CVD) mortality of the RF, that established in 2006 in women and in men. From 2003 to 2013 y. total coefficient of cardiovascular mortality (number of died per 100 thousand of population) decreased by 25% (698,1 vs. 927,5), although still it is higher than in the beginning of the nineties (621,0 per 100 thous. of population in 1991 y.). The significant differences in RG regions are noted by the values of morbidity and mortality from CVD. For the period 2006-2013 y. the standardized value of mortality from coronary heart disease (CHD) in Moscow decreased by 35,7% that is 1,5 more than in RF and 1,3 more higher than in St-Petersburg, and 2,6 times more than in Moscow region. In 2012 the value of the suspected life duration (SLD) of Moscow citizens was 76,0 y. (mean in Russia — 70,0 y), and just 4 years is the gap between then and EU citizens. In 2013 SLD in Moscow reached 72,3 y. Significantly lower values of mortality from CVD and higher values of SLD can be explained by higher socio-economic level, higher psychological endurance and better availability of psychological (psychotherapeutic) help, higher level of fish, fruits and berries consumption, better availability of outpatient and high technology medical care for Moscow citizens. 

scholarly journals The Impact of the Introduction of Clinical Recommendations on Cardiology in the USA and Russia Federetionon Mortality from Ischemic Heart Diseas

2018 ◽  
Vol 17 (4) ◽  
pp. 30-37
Author(s):  
A. A. Gerasimov
Keyword(s):  
United States ◽  
Coronary Heart Disease ◽  
Heart Disease ◽  
Ischemic Heart Disease ◽  
Russian Federation ◽  
Clinical Guidelines ◽  
The United States ◽  
Ischemic Heart ◽  
The Russian Federation ◽  
The Impact

1 million 824 thousand people died in the Russian Federation in 2017, including 457 thousand from ischemic heart disease (IHD). IHD caused more than a quarter of deaths in Russia. Goal. The article analyzes the impact of implementation of clinical guidelines in cardiology in medical practice in the United States and the Russian Federation on the dynamics of mortality from ischemic heart disease and its outcomes in different age groups. Results. The results showed that the implementation of clinical guidelines (CG) increased the rate of mortality reduction from coronary heart diseases in Russia and the United States, which may indicate a positive impact CG on the quality of medical care. Conclusions. A higher level of mortality from coronary heart disease in Russia compared to the United States may be due to less commitment of doctors to the principles of therapy and diagnosis of various forms of coronary heart disease, set out in clinical guidelines.

scholarly journals Choosing an antianginal therapy strategy in patients with stable coronary artery disease in real clinical practice: the advantages of trimetazidine

2021 ◽  
pp. 25-32
Author(s):  
E. V. Borisova ◽  
O. D. Ostroumova ◽  
A. P. Pereverzev ◽  
E. E. Pavleeva
Keyword(s):  
Coronary Heart Disease ◽  
Heart Disease ◽  
Russian Federation ◽  
Stable Coronary Artery Disease ◽  
Cardiovascular Complications ◽  
Ministry Of Health ◽  
Conduction Disorders ◽  
Therapy Strategy ◽  
Stable Coronary Heart Disease ◽  
The Russian Federation

Cardiovascular diseases (CVD) are the leading cause of death among adults worldwide, including in the Russian Federation. At the same time, the leading position in the structure of causes of death from CVD is occupied by coronary heart disease (CHD) (16% of the total number of deaths in the world per year). The new clinical guidelines of the Ministry of Health of the Russian Federation for the management of patients with stable coronary heart disease in 2020 identify two main goals of conservative therapy – the elimination of symptoms of the disease and the prevention of cardiovascular complications (CVD). In this connection, when choosing antianginal therapy in patients with stable angina, it is necessary to consider the possibility of using combinations of both first-line and second-line drugs in order to really improve the effectiveness of treatment and achieve the goals set. It is advisable and justified to use more widely 2-line drugs, in particular trimetazidine, at any stage of therapy to enhance the antianginal effectiveness of b-blockers, calcium antagonists and prolonged-acting nitrates, especially in patients with hemodynamic features (arterial hypotension, rhythm and conduction disorders), which is demonstrated in the given clinical example. The effective addition of tremetazidine to the arsenal of traditional antianginal drugs is legislated in practice and is reflected in the new clinical recommendations of the Ministry of Health of the Russian Federation in 2020. The accumulated experience of using trimetazidine allows a pathogenetically sound approach to the treatment of stable CHD, restoring the balance between the need and delivery of oxygen to the heart muscle, and the safety profile expands the possibilities of use in patients with comorbid pathology. 

The Results of the External Audit of Medical Care for Children with Cancer in one of the Regions of the Russian Federation

2016 ◽  
Vol 3 (2) ◽  
pp. 67-79
Author(s):  
M.Yu. Rykov ◽  
◽  
E.N. Baibarina ◽  
O.V. Chumakova ◽  
V.G. Polyakov ◽  
...  
Keyword(s):  
Medical Care ◽  
Russian Federation ◽  
External Audit ◽  
Children With Cancer ◽  
The Russian Federation

Recommendations of the Ministry of Health of the Russian Federation on the formation of a temporary staff table of a medical organization providing medical care to citizens with coronavirus infection COVID-19

2020 ◽  
pp. 5-12
Author(s):  
Olga Shinkareva
Keyword(s):  
Medical Care ◽  
Russian Federation ◽  
Medical Organization ◽  
Ministry Of Health ◽  
Organization Of Work ◽  
Coronavirus Infection ◽  
The Russian Federation

Article is devoted to the analysis of the Order of the Russian Ministry of Health of 19.03.2020 № 198n (an edition of 29.04.2020) “About a temporary order of the organization of work of the medical organizations for implementation of measures for prevention and reduction of risk of spread of a new koronavirusny infection of COVID19” regarding formation of the temporary staff list of the division of the medical organization providing medical care to citizens with a koronavirusny infection of COVID-19 and also the requirement with the staff of this division. The criteria recommended by the Ministry of Health of the Russian Federation for determining the number of rates of medical workers in these divisions, requirements for medical workers of the division have been considered, a practical example of calculation of rates has been given.

scholarly journals Dietary Soy Consumption and Cardiovascular Mortality among Chinese People with Type 2 Diabetes

Nutrients ◽  
2021 ◽  
Vol 13 (8) ◽  
pp. 2513
Author(s):  
Xiaowen Wang ◽  
Jun Lv ◽  
Canqing Yu ◽  
Liming Li ◽  
Yonghua Hu ◽  
...  
Keyword(s):  
Myocardial Infarction ◽  
Acute Myocardial Infarction ◽  
Coronary Heart Disease ◽  
Heart Disease ◽  
Food Consumption ◽  
Cardiovascular Mortality ◽  
International Classification Of Diseases ◽  
Cardiovascular Death ◽  
Soy Foods ◽  
Cox Proportional Hazard Regression

Randomized controlled trials showed that soy intervention significantly improved blood lipids in people with diabetes. We sought to prospectively examine the association of soy consumption with the risk of cardiovascular death among individuals with diabetes. A total of 26,139 participants with a history of diabetes were selected from the Chinese Kadoorie Biobank study. Soy food consumption was assessed by a food frequency questionnaire. Causes of death were coded by the 10th International Classification of Diseases. The Cox proportional hazard regression was used to compute the hazard ratios. During a median follow-up of 7.8 years, a total of 1626 deaths from cardiovascular disease (CVD) were recorded. Compared with individuals who never consumed soy foods, the multivariable-adjusted risks (95% confidence intervals) of CVD mortality were 0.92 (0.78, 1.09), 0.89 (0.75, 1.05), and 0.77 (0.62, 0.96) for those who consumed soy foods monthly, 1–3 days/week, and ≥4 days/week, respectively. For cause-specific cardiovascular mortality, significant inverse associations were observed for coronary heart disease and acute myocardial infarction. Higher soy food consumption was associated with a lower risk of cardiovascular death, especially death from coronary heart disease and acute myocardial infarction, in Chinese adults with diabetes.

Exercise cardiac power and the risk of coronary heart disease and cardiovascular mortality in men

2016 ◽  
Vol 48 (8) ◽  
pp. 625-630 ◽  
Author(s):  
Sudhir Kurl ◽  
Timo Mäkikallio ◽  
Sae Young Jae ◽  
Kimmo Ronkainen ◽  
Jari A. Laukkanen
Keyword(s):  
Coronary Heart Disease ◽  
Heart Disease ◽  
Cardiovascular Mortality ◽  
Cardiac Power
Sign in / Sign up

Export Citation Format

Share Document